Ncardia launches iPSCbased phenotypic screening service

Ncardia launches iPSC-based phenotypic screening service

06:56 EST 5 Feb 2019 | Compelo Medical Devices

The new service enables researchers to access human disease-relevant biology earlier in the drug discovery process with the goal of bringing better medicines to patients faster. The DiscoverHIT

The post Ncardia launches iPSC-based phenotypic screening service appeared first on Compelo Medical Devices.

Original Article: Ncardia launches iPSC-based phenotypic screening service

More From BioPortfolio on "Ncardia launches iPSC-based phenotypic screening service"